282 related articles for article (PubMed ID: 32641983)
1. Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant
Chen G; Bai Y; Li Z; Wang F; Fan X; Zhou X
Theranostics; 2020; 10(16):7131-7149. PubMed ID: 32641983
[No Abstract] [Full Text] [Related]
2. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.
Brady RA; Mocca CP; Prabhakara R; Plaut RD; Shirtliff ME; Merkel TJ; Burns DL
PLoS One; 2013; 8(4):e63040. PubMed ID: 23658662
[TBL] [Abstract][Full Text] [Related]
4. Cross-protective effect of a novel multi-antigen-chimeric vaccine against Streptococcus and Staphylococcus aureus infection in mice.
Yu L; Fan Z; Ma J; Tong C; Song B; Zhu Z; Cui Y
J Med Microbiol; 2014 Dec; 63(Pt 12):1732-1740. PubMed ID: 25288644
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus toxin suppresses antigen-specific T cell responses.
Lee B; Olaniyi R; Kwiecinski JM; Wardenburg JB
J Clin Invest; 2020 Mar; 130(3):1122-1127. PubMed ID: 31873074
[TBL] [Abstract][Full Text] [Related]
6. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity.
Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK
PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035
[TBL] [Abstract][Full Text] [Related]
7. Folic acid-modified mesoporous silica nanoparticles with pH-responsiveness loaded with Amp for an enhanced effect against anti-drug-resistant bacteria by overcoming efflux pump systems.
Chen X; Liu Y; Lin A; Huang N; Long L; Gang Y; Liu J
Biomater Sci; 2018 Jun; 6(7):1923-1935. PubMed ID: 29850668
[TBL] [Abstract][Full Text] [Related]
8. Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections.
Mocca CP; Brady RA; Burns DL
Clin Vaccine Immunol; 2014 May; 21(5):622-7. PubMed ID: 24574539
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
[TBL] [Abstract][Full Text] [Related]
10. Harnessing antifungal immunity in pursuit of a Staphylococcus aureus vaccine strategy.
Paterson MJ; Caldera JR; Nguyen C; Sharma P; Castro AM; Kolar SL; Tsai CM; Limon JJ; Becker CA; Martins GA; Liu GY; Underhill DM
PLoS Pathog; 2020 Aug; 16(8):e1008733. PubMed ID: 32817694
[TBL] [Abstract][Full Text] [Related]
11. Release of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform.
Wang X; Thompson CD; Weidenmaier C; Lee JC
Nat Commun; 2018 Apr; 9(1):1379. PubMed ID: 29643357
[TBL] [Abstract][Full Text] [Related]
12. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
[TBL] [Abstract][Full Text] [Related]
13. A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
Moscoso M; García P; Cabral MP; Rumbo C; Bou G
Virulence; 2018 Jan; 9(1):604-620. PubMed ID: 29297750
[TBL] [Abstract][Full Text] [Related]
14.
Clegg J; Soldaini E; McLoughlin RM; Rittenhouse S; Bagnoli F; Phogat S
Front Immunol; 2021; 12():705360. PubMed ID: 34305945
[No Abstract] [Full Text] [Related]
15. Improved protective efficacy of a chimeric Staphylococcus aureus vaccine candidate iron-regulated surface determinant B ( N 126- P 361) -target of RNAIII activating protein in mice.
Yu L; Wang N; Ma J; Tong C; Song B; Chi J; Ma G; Zhu Z; Cui Y
Microbiol Immunol; 2013 Dec; 57(12):857-64. PubMed ID: 24117875
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a Staphylococcus aureus-cholera toxin A
Misra N; Wines TF; Knopp CL; Hermann R; Bond L; Mitchell B; McGuire MA; Tinker JK
Vaccine; 2018 Jun; 36(24):3513-3521. PubMed ID: 29739718
[TBL] [Abstract][Full Text] [Related]
17. CD8α
Zhang W; Xu L; Zhang X; Xu J; Jin JO
Immunology; 2020 Apr; 159(4):404-412. PubMed ID: 31909831
[TBL] [Abstract][Full Text] [Related]
18. Design of
Soltan MA; Magdy D; Solyman SM; Hanora A
OMICS; 2020 Apr; 24(4):195-204. PubMed ID: 32286190
[TBL] [Abstract][Full Text] [Related]
19. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Staphylococcal Antigen-F (r-ScaF), a novel vaccine candidate against methicillin resistant Staphylococcus aureus infection: Potency and efficacy studies.
Majelan PA; Mahdavi M; Yazdi MH; Salimi E; Pourmand MR
Microb Pathog; 2019 Feb; 127():159-165. PubMed ID: 30521844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
